Organ Transplant Diagnostics Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,900	111 Pages	TechSci Research	June, 2023	TCSI18000150

Best Price Guarantee
Price	from $4,900
Length	111 Pages
Publisher	TechSci Research
Published Date	June, 2023
SKU	TCSI18000150

Organ Transplant Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Component (Kits & Assays, Consumables, Services), By Transplant Type (Solid Organ Transplant v/s Stem Cell Transplant), By Technology (Molecular Technologies, Serology, Flow Cytometry, Others), By Application (Clinical Diagnostics v/s Translational Research), By End User (Hospitals & Transplant Centers, Academic & Research Institutions, Others), By company and By Region

The global organ transplant diagnostics market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the growing prevalence of chronic diseases, the increase in the number of organ transplantation surgeries, and the adoption of advanced technology in the field of transplant diagnostics, which are impelling the growth of the market. Organ transplantation is a medical technique in which an organ is removed from one body and placed in a recipient’s body to substitute a damaged or missing organ. The other factors supporting the market’s growth are, increasing government initiatives for spreading awareness, the rising geriatric population, the rising incidence of organ failure, high demand for molecular diagnostic tests, the surging investment and expenditure in healthcare and diagnostics, growing number of the organ transplant procedure, growing launch of programs & new product development in organ transplant diagnosis, and rise in research and development activities.

Rising Incidences of Chronic diseases

The increasing occurrence of chronic diseases, such as diabetes, cardiovascular diseases, and others, across the globe, are bolstering the growth of the market. This is attributed to the increased risk of organ failure among patients suffering from chronic diseases. According to the WHO, Cardiovascular diseases (CVDs) are the leading cause of death worldwide, taking approximately 17.9 million lives each year. Also, the geriatric population is more prone to organ malfunction, especially the liver, heart, and kidney, thus, in turn, driving the growth of the market. As per the United States Government Information on Organ Donation and Transplantation, in 2019, 63 % of those who had organ transplants were aged 50 or older, and 21% of overall organ transplant individuals were aged 65 and above.

Increasing Awareness and Increase in the Number of Organ Transplantation Surgeries

Over the past few years, people are becoming more aware of organ transplantation, which is augmenting the growth of the market. Owing to the awareness among the masses, people are going for organ transplantation surgeries, which is fueling the growth of the market. Various initiatives are taken by the government and non-government organizations to make people aware of organ transplantation. Moreover, the rise in number of organ transplantation surgeries is fueling the growth of the market. Owing to the increase in the number of patients with organ failure, the demand for transplant procedures is rising, which is facilitating the growth of the market. According to Health Resources and Services Administration, in 2019, about 112,568 people in the U.S. required organ transplantation.

Market Segmentation

The global organ transplant diagnostics market is segmented into component, transplant type, technology, application, end-user, and company. Based on components, the market is divided into kits & assays, consumables, and services. Based on transplant type, the market is divided into solid organ transplants and stem cell transplants. Based on technology, the market is segmented into molecular technologies, serology, flow cytometry, and others. Based on application, the market is divided into clinical diagnostics and translational research. Based on end-user, the market is divided into hospitals & transplant centers, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rise in the number of organ transplantation surgeries in the country.

Market Players

Illumina, Inc., Thermo Fischer Scientific, Inc., Abbott Laboratories, Inc., Quest Diagnostics, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Laboratory Corporation of America Holdings, bioMérieux S.A., CareDx, Inc, and Immucor, Inc. are some of the leading companies operating in the market.

Report Scope:

In this report, global organ transplant diagnostics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organ Transplant Diagnostics Market, By Component:
Kits & Assays
Consumables
Services
Organ Transplant Diagnostics Market, By Transplant Type:
Solid Organ Transplant
Stem Cell Transplant
Organ Transplant Diagnostics Market, By Technology:
Molecular Technologies
Serology
Flow Cytometry
Others
Organ Transplant Diagnostics Market, By Application:
Clinical Diagnostics
Translational Research
Organ Transplant Diagnostics Market, By End User:
Hospitals & Transplant Centers
Academic & Research Institutions
Others
Organ Transplant Diagnostics Market, By Region:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
Australia
South Korea
Europe & CIS
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Turkey
Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Organ Transplant Diagnostics Market

Company Information

Detailed analysis and profiling of additional market players (up to five).

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Organ Transplant Diagnostics Market
5. Voice of Customer
6. Global Organ Transplant Diagnostics Market Outlook: 6.1. Market Size & Forecast; 6.1.1. By Value; 6.2. Market Share & Forecast; 6.2.1. By Component (Kits & Assays, Consumables, Services); 6.2.2. By Transplant Type (Solid Organ Transplant v/s Stem Cell Transplant); 6.2.3. By Technology (Molecular Technologies, Serology, Flow Cytometry, Others); 6.2.4. By Application (Clinical Diagnostics v/s Translational Research); 6.2.5. By End User (Hospitals & Transplant Centers, Academic & Research Institutions, Others); 6.2.6. By Company (2021); 6.2.7. By Region; 6.3. Market Map
7. North America Organ Transplant Diagnostics Market Outlook: 7.1. Market Size & Forecast; 7.1.1. By Value; 7.2. Market Share & Forecast; 7.2.1. By Component; 7.2.2. By Transplant Type; 7.2.3. By Technology; 7.2.4. By Application; 7.2.5. By End User; 7.2.6. By Country; 7.3. North America: Country Analysis; 7.3.1. United States Organ Transplant Diagnostics Market Outlook; 7.3.1.1. Market Size & Forecast; 7.3.1.1.1. By Value; 7.3.1.2. Market Share & Forecast; 7.3.1.2.1. By Component; 7.3.1.2.2. By Transplant Type; 7.3.1.2.3. By Technology; 7.3.1.2.4. By Application; 7.3.1.2.5. By End User; 7.3.2. Canada Organ Transplant Diagnostics Market Outlook; 7.3.2.1. Market Size & Forecast; 7.3.2.1.1. By Value; 7.3.2.2. Market Share & Forecast; 7.3.2.2.1. By Component; 7.3.2.2.2. By Transplant Type; 7.3.2.2.3. By Technology; 7.3.2.2.4. By Application; 7.3.2.2.5. By End User; 7.3.3. Mexico Organ Transplant Diagnostics Market Outlook; 7.3.3.1. Market Size & Forecast; 7.3.3.1.1. By Value; 7.3.3.2. Market Share & Forecast; 7.3.3.2.1. By Component; 7.3.3.2.2. By Transplant Type; 7.3.3.2.3. By Technology; 7.3.3.2.4. By Application; 7.3.3.2.5. By End User
8. Europe Organ Transplant Diagnostics Market Outlook: 8.1. Market Size & Forecast; 8.1.1. By Value; 8.2. Market Share & Forecast; 8.2.1. By Component; 8.2.2. By Transplant Type; 8.2.3. By Technology; 8.2.4. By Application; 8.2.5. By End User; 8.2.6. By Country; 8.3. Europe: Country Analysis; 8.3.1. France Organ Transplant Diagnostics Market Outlook; 8.3.1.1. Market Size & Forecast; 8.3.1.1.1. By Value; 8.3.1.2. Market Share & Forecast; 8.3.1.2.1. By Component; 8.3.1.2.2. By Transplant Type; 8.3.1.2.3. By Technology; 8.3.1.2.4. By Application; 8.3.1.2.5. By End User; 8.3.2. Germany Organ Transplant Diagnostics Market Outlook; 8.3.2.1. Market Size & Forecast; 8.3.2.1.1. By Value; 8.3.2.2. Market Share & Forecast; 8.3.2.2.1. By Component; 8.3.2.2.2. By Transplant Type; 8.3.2.2.3. By Technology; 8.3.2.2.4. By Application; 8.3.2.2.5. By End User; 8.3.3. United Kingdom Organ Transplant Diagnostics Market Outlook; 8.3.3.1. Market Size & Forecast; 8.3.3.1.1. By Value; 8.3.3.2. Market Share & Forecast; 8.3.3.2.1. By Component; 8.3.3.2.2. By Transplant Type; 8.3.3.2.3. By Technology; 8.3.3.2.4. By Application; 8.3.3.2.5. By End User; 8.3.4. Italy Organ Transplant Diagnostics Market Outlook; 8.3.4.1. Market Size & Forecast; 8.3.4.1.1. By Value; 8.3.4.2. Market Share & Forecast; 8.3.4.2.1. By Component; 8.3.4.2.2. By Transplant Type; 8.3.4.2.3. By Technology; 8.3.4.2.4. By Application; 8.3.4.2.5. By End User; 8.3.5. Spain Organ Transplant Diagnostics Market Outlook; 8.3.5.1. Market Size & Forecast; 8.3.5.1.1. By Value; 8.3.5.2. Market Share & Forecast; 8.3.5.2.1. By Component; 8.3.5.2.2. By Transplant Type; 8.3.5.2.3. By Technology; 8.3.5.2.4. By Application; 8.3.5.2.5. By End User
9. Asia-Pacific Organ Transplant Diagnostics Market Outlook: 9.1. Market Size & Forecast; 9.1.1. By Value; 9.2. Market Share & Forecast; 9.2.1. By Component; 9.2.2. By Transplant Type; 9.2.3. By Technology; 9.2.4. By Application; 9.2.5. By End User; 9.2.6. By Country; 9.3. Asia-Pacific: Country Analysis; 9.3.1. China Organ Transplant Diagnostics Market Outlook; 9.3.1.1. Market Size & Forecast; 9.3.1.1.1. By Value; 9.3.1.2. Market Share & Forecast; 9.3.1.2.1. By Component; 9.3.1.2.2. By Transplant Type; 9.3.1.2.3. By Technology; 9.3.1.2.4. By Application; 9.3.1.2.5. By End User; 9.3.2. India Organ Transplant Diagnostics Market Outlook; 9.3.2.1. Market Size & Forecast; 9.3.2.1.1. By Value; 9.3.2.2. Market Share & Forecast; 9.3.2.2.1. By Component; 9.3.2.2.2. By Transplant Type; 9.3.2.2.3. By Technology; 9.3.2.2.4. By Application; 9.3.2.2.5. By End User; 9.3.3. Japan Organ Transplant Diagnostics Market Outlook; 9.3.3.1. Market Size & Forecast; 9.3.3.1.1. By Value; 9.3.3.2. Market Share & Forecast; 9.3.3.2.1. By Component; 9.3.3.2.2. By Transplant Type; 9.3.3.2.3. By Technology; 9.3.3.2.4. By Application; 9.3.3.2.5. By End User; 9.3.4. South Korea Organ Transplant Diagnostics Market Outlook; 9.3.4.1. Market Size & Forecast; 9.3.4.1.1. By Value; 9.3.4.2. Market Share & Forecast; 9.3.4.2.1. By Component; 9.3.4.2.2. By Transplant Type; 9.3.4.2.3. By Technology; 9.3.4.2.4. By Application; 9.3.4.2.5. By End User; 9.3.5. Australia Organ Transplant Diagnostics Market Outlook; 9.3.5.1. Market Size & Forecast; 9.3.5.1.1. By Value; 9.3.5.2. Market Share & Forecast; 9.3.5.2.1. By Component; 9.3.5.2.2. By Transplant Type; 9.3.5.2.3. By Technology; 9.3.5.2.4. By Application; 9.3.5.2.5. By End User
10. South America Organ Transplant Diagnostics Market Outlook: 10.1. Market Size & Forecast; 10.1.1. By Value; 10.2. Market Share & Forecast; 10.2.1. By Component; 10.2.2. By Transplant Type; 10.2.3. By Technology; 10.2.4. By Application; 10.2.5. By End User; 10.2.6. By Country; 10.3. South America: Country Analysis; 10.3.1. Brazil Organ Transplant Diagnostics Market Outlook; 10.3.1.1. Market Size & Forecast; 10.3.1.1.1. By Value; 10.3.1.2. Market Share & Forecast; 10.3.1.2.1. By Component; 10.3.1.2.2. By Transplant Type; 10.3.1.2.3. By Technology; 10.3.1.2.4. By Application; 10.3.1.2.5. By End User; 10.3.2. Argentina Organ Transplant Diagnostics Market Outlook; 10.3.2.1. Market Size & Forecast; 10.3.2.1.1. By Value; 10.3.2.2. Market Share & Forecast; 10.3.2.2.1. By Component; 10.3.2.2.2. By Transplant Type; 10.3.2.2.3. By Technology; 10.3.2.2.4. By Application; 10.3.2.2.5. By End User; 10.3.3. Colombia Organ Transplant Diagnostics Market Outlook; 10.3.3.1. Market Size & Forecast; 10.3.3.1.1. By Value; 10.3.3.2. Market Share & Forecast; 10.3.3.2.1. By Component; 10.3.3.2.2. By Transplant Type; 10.3.3.2.3. By Technology; 10.3.3.2.4. By Application; 10.3.3.2.5. By End User
11. Middle East and Africa Organ Transplant Diagnostics Market Outlook: 11.1. Market Size & Forecast; 11.1.1. By Value; 11.2. Market Share & Forecast; 11.2.1. By Component; 11.2.2. By Transplant Type; 11.2.3. By Technology; 11.2.4. By Application; 11.2.5. By End User; 11.2.6. By Country; 11.3. MEA: Country Analysis; 11.3.1. South Africa Organ Transplant Diagnostics Market Outlook; 11.3.1.1. Market Size & Forecast; 11.3.1.1.1. By Value; 11.3.1.2. Market Share & Forecast; 11.3.1.2.1. By Component; 11.3.1.2.2. By Transplant Type; 11.3.1.2.3. By Technology; 11.3.1.2.4. By Application; 11.3.1.2.5. By End User; 11.3.2. Saudi Arabia Organ Transplant Diagnostics Market Outlook; 11.3.2.1. Market Size & Forecast; 11.3.2.1.1. By Value; 11.3.2.2. Market Share & Forecast; 11.3.2.2.1. By Component; 11.3.2.2.2. By Transplant Type; 11.3.2.2.3. By Technology; 11.3.2.2.4. By Application; 11.3.2.2.5. By End User; 11.3.3. UAE Organ Transplant Diagnostics Market Outlook; 11.3.3.1. Market Size & Forecast; 11.3.3.1.1. By Value; 11.3.3.2. Market Share & Forecast; 11.3.3.2.1. By Component; 11.3.3.2.2. By Transplant Type; 11.3.3.2.3. By Technology; 11.3.3.2.4. By Application; 11.3.3.2.5. By End User; 11.3.4. Turkey Organ Transplant Diagnostics Market Outlook; 11.3.4.1. Market Size & Forecast; 11.3.4.1.1. By Value; 11.3.4.2. Market Share & Forecast; 11.3.4.2.1. By Component; 11.3.4.2.2. By Transplant Type; 11.3.4.2.3. By Technology; 11.3.4.2.4. By Application; 11.3.4.2.5. By End User; 11.3.5. Egypt Organ Transplant Diagnostics Market Outlook; 11.3.5.1. Market Size & Forecast; 11.3.5.1.1. By Value; 11.3.5.2. Market Share & Forecast; 11.3.5.2.1. By Component; 11.3.5.2.2. By Transplant Type; 11.3.5.2.3. By Technology; 11.3.5.2.4. By Application; 11.3.5.2.5. By End User
12. Market Dynamics: 12.1. Drivers; 12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape: 14.1. Illumina, Inc.; 14.2. Thermo Fischer Scientific, Inc.; 14.3. Abbott Laboratories, Inc.; 14.4. Quest Diagnostics, Inc.; 14.5. F. Hoffmann-La Roche AG; 14.6. Bio-Rad Laboratories, Inc.; 14.7. Laboratory Corporation of America Holdings; 14.8. bioMérieux S.A.; 14.9. CareDx, Inc; 14.10. Immucor, Inc.
15. Strategic Recommendations